Livocab

Livocab is owned by UCB, headquartered in Belgium. No. The ultimate owner of Livocab, UCB, is headquartered in Belgium, not in the United States.

UCB is a global biopharmaceutical company focused on developing innovative medicines, particularly in the fields of neurology and immunology.